This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Exec Summary: The HealthTech sector is poised for significant M&A activity in 2025, driven by several key trends: DigitalHealth Solutions: The increasing demand for digitalhealth solutions to improve healthcare accessibility and efficiency will drive acquisitions of innovative startups and established players in this space.
Overall, HLTH 2024 is expected to be a thought-provoking and informative event that will shape the future of healthcare. Nelson Advisors work with HealthcareTechnology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Subscribe Today!
With significant investments and a focus on innovation, Merative is poised to play a major role in shaping the future of healthcare data analytics and technology. HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Subscribe Today! Subscribe Today!
By effectively applying the Value Net Framework, HealthTech companies can navigate the complex and dynamic healthcare landscape, identify new opportunities, and ultimately improve patient care and outcomes. HealthcareTechnology Thought Leadership from Nelson Advisors Market Insights, Analysis & Predictions.
Digitalhealth funding pre pandemic: 2018 Digitalhealth companies raised a total of $8.1 There were 368 deals in the digitalhealth space in 2018, with an average deal size of $22.2 Other areas that received significant investment included telemedicine, digital therapeutics, and health insurance technology.
According to a McKinsey report, an estimated 25% of outpatient services could move to telemedicine, which is among the necessary changes that could mean preparation and prevention for future health epidemics and pandemics, said Dr. Muhammad Ali Chaudhry, CEO of Emerging Health International, a healthcaretechnology and services company.
In the context of healthtech and digitalhealth, it means a company initially targets consumers (B2C), builds a strong user base, and then leverages this consumer adoption to attract businesses (B2B), such as insurers, employers, or healthcare providers. Exec Summary: B2C2B stands for Business-to-Consumer-to-Business.
Comparatively, the healthcare sector has lagged in recent years, but 2025 is showing signs of a turnaround. While giants like UnitedHealth or biotech stars like Vertex Pharmaceuticals often dominate headlines, Doximitys niche focus and execution have propelled it ahead. Subscribe Today! Subscribe Today!
“Our team’s extensive experience with investments within the specialty pharmaceutical ecosystem has deepened our appreciation for SamaCare’s pivotal role in helping patients start and stay on their treatment regimens, ultimately leading to better outcomes.”
Exec Summary: Orforglipron was originally discovered and developed by Chugai Pharmaceutical Co., Mergers, Acquisitions, Growth and Strategy for HealthcareTechnology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk
“Adding Blackford and its AI technology to our radiology portfolio secures Bayer an excellent position in the fastest growing segment within the overall global radiology industry,” said Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer’s Pharmaceutical Division.
“The relationship between Mass General Brigham’s commercial AI business (Mass General Brigham AI) and GE HealthCare has helped accelerate the introduction of AI into a range of product offerings and digitalhealth solutions. ” To learn more about GE HealthCare’sdigital and AI technologies, visit here.
The collaboration seeks to better equip clinicians with technology to precisely diagnose and treat medical conditions and personalize the patient experience at each step of their care journey through the clinical translation of novel technologies and approaches to medical imaging and theranostics. “We We are an $18.3
Colin is a proven leader with a deep understanding of the digitalhealthtechnology industry. Colin and I will be working together — combining our strengths to build on our company’s success in developing and delivering real-world digital clinical measures and taking the company to new heights.” We are on Twitter.
This is due to a number of factors, including: The increasing prevalence of chronic diseases The rising cost of healthcare The increasing demand for patient-centered care As a result, DTx companies are still expected to be attractive targets for M&A deals. The average deal size for DTx M&A deals is increasing. Subscribe Today!
The agreements stand on two key pillars and will deepen OSF HealthCare, Pointcore and GE HealthCare’s combined focus on: A foundational alliance that includes investment in new technology systems, digital tools and resources, service and support across a variety of care areas including nuclear medicine, oncology and radiology.
The impact of digitalhealth: Digitalhealthtechnologies are transforming the way healthcare is delivered. The conference is likely to feature discussions on the latest digitalhealth trends, as well as the impact of digitalhealth on the pharmaceutical industry and the overall healthcare system.
GE HealthCare’s Critical Care Suite was co-developed with UCSF’s Center for DigitalHealth Innovation (CDHI) and the company’s AMX platform is the first mobile X-ray system in the world to offer this on-device embedded artificial intelligence for triage. About GE HealthCareTechnologies Inc. We are an $18.3
These are a few potential big healthtech M&A deals that could happen in 2024: Amazon acquiring Teladoc Health. The combined company would be a major player in the digitalhealth space, with a reach of millions of patients. This deal would give Apple a major foothold in the healthcare insurance market. Subscribe Today!
In addition to these core areas, there will likely be discussions on specific sectors within healthcare, such as pharmaceuticals, medical management, and healthcare delivery models. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.
Drozdowicz joins the company from Bayer Pharmaceuticals where he most recently served as Head of Integrated Care. In this role, he built and led a world-class team of professionals that developed and grew a portfolio of digitalhealth companies, and drove successful expansion into new markets.
Exec Summary: Scotland has emerged as a global leader in the field of digitalhealth and care, driven by a combination of factors: A strong foundation in medical innovation: Scotland boasts a rich history of medical breakthroughs, from the world's first cloned sheep (Dolly) to pioneering research in stem cell therapy.
They might target smaller, innovative companies with niche solutions or complementary technologies at reasonable valuations. Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making.
Digitalhealth funding has dropped to levels not seen since 2016 , with just $3 billion in global funding announced in Q3, according to the latest report from CB Insights. Only 17% of healthcaretechnology VCs said generative AI is “significantly” changing their investment strategy , according to a poll from GSR Ventures.
Corporate Development for HealthcareTechnology companies in EMEA HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Drug development: Pharmaceutical companies like Novo Nordisk, Eli Lilly, and AstraZeneca led the development and commercialization of GLP-1 RAs.
Bardy Diagnostics is a digitalhealth and remote patient monitoring company focused on addressing a long-standing complaint by cardiac electrophysiologists and cardiologists regarding their frequent inability to clearly distinguish the P-wave on ECG strips of existing monitors. iRhythm Technologies. Bardy Diagnostics.
Recent Investments NVentures has made several notable investments in healthcare startups, including: Hippocratic AI: A company focused on developing safe and effective large language models for healthcare applications. Recursion Pharmaceuticals: A biotech company using AI to discover new drug candidates. Why Healthcare?
If you’ve heard of American Well, you know we are a Boston-based digitalhealth company and a leader in the telehealth space. and recently, there is even greater interest from Israeli-led healthcare and technology firms in moving to the state. Ido: Boston is in many ways the healthcare capital of America.
Visit www.nelsonadvisors.co.uk > HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, DigitalHealth Insights and Analysis. Email lloyd@nelsonadvisors.co.uk > HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
Mergers, Acquisitions, Growth and Strategy for HealthcareTechnology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, DigitalHealth Insights and Analysis.
AI Business Development and Partnerships: Altman's experience in building successful businesses will be invaluable in translating AI technologies into viable healthcare solutions. AI Advocacy and Public Engagement: Altman is a strong advocate for the use of AI to address global challenges, including healthcare. Subscribe Today!
A pharmaceutical company can use AI to develop new drugs and treatments more quickly and efficiently. Subscribe today! , [link] HealthTech, Health IT, DigitalHealth M&A Advisory Services for Founders, Shareholders and Investors. It includes a wide range of technologies, such as telehealth, EHRs, and wearable devices.
With a growing number of startups and established companies developing innovative solutions, we can expect to see significant improvements in healthcare access and affordability on the continent in the coming years. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, DigitalHealth Insights and Analysis.
Mergers, Acquisitions, Growth and Strategy for HealthcareTechnology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, DigitalHealth Insights and Analysis.
By implementing these strategies, Palantir can effectively address public concerns, build trust, and gain acceptance for its role in delivering the NHS Federated Data Platform, ultimately contributing to improved patient care and healthcare outcomes in England. Palantir's plans for healthcare are ambitious. Subscribe Today!
Exec Summary: Private equity firms have traditionally focused on investing in large, high-growth healthcaretechnology companies. Private equity firms can acquire digital therapeutics companies and help them to scale their operations and reach more patients. However, they are unlikely to reach billion-dollar valuations.
With the additional funding and board appointments, we are set to accelerate the validation of our approach by advancing multiple programs and partnerships toward the ultimate test of any biopharma technology platform – human clinical trials.” Dr. Rhodes currently serves as Executive Chair of the Board at Pheno Therapeutics.
If you’ve heard of Amwell, you know we are a Boston-based digitalhealth company and a leader in the telehealth space. and recently, there is even greater interest from Israeli-led healthcare and technology firms in moving to the state. Ido: Boston is in many ways the healthcare capital of America.
If you’ve heard of American Well, you know we are a Boston-based digitalhealth company and a leader in the telehealth space. and recently, there is even greater interest from Israeli-led healthcare and technology firms in moving to the state. Ido: Boston is in many ways the healthcare capital of America.
HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, DigitalHealth Insights and Analysis. Subscribe Today! Subscribe Today!
Released in 2015, the device quickly began to eat into the traditional wearables market, and was a natural conduit to feed health metrics into HealthKit. That move was followed in 2016 by the announcement of CareKit, which allows developers to build their own health management programs and plans.
The agreement will allow Sensyne Health to analyse anonymised patient data using clinical artificial intelligence (Clinical AI) technology*. The agreement also includes a new research collaboration between the parties in digitalhealth and biomedical research. Source : [link]
Case Study 2: BT British Telecom (BT) is also a major player in the UK healthcaretechnology market. BT offers a range of solutions to help healthcare organisations improve the quality and efficiency of care delivery. The development of new blockchain-based healthcare solutions.
Digitalhealth solutions are making it easier, quicker and more responsive to adjust a patient’s therapy according to the results and discuss it directly and virtually, in real time. . Before the pandemic, technology had been largely on the back-foot in most hospitals.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content